EcoDrugPlus

Ensembl ID : ENSBBBG00000021462
Gene Symbol: -
Cross references: -
376 Possible Orthologues:

Ensembl ID : ENSBBBG00000025486
Gene Symbol: -
Cross references: -
298 Possible Orthologues:

Ensembl ID : ENSBBBG00000019470
Gene Symbol: -
Cross references: -
206 Possible Orthologues:

Ensembl ID : ENSBBBG00000019398
Gene Symbol: -
Cross references: -
228 Possible Orthologues:

Ensembl ID : ENSBBBG00000017467
Gene Symbol: -
Cross references: -
274 Possible Orthologues:

Ensembl ID : ENSBBBG00000017457
Gene Symbol: -
Cross references: -
274 Possible Orthologues:

Ensembl ID : ENSBBBG00000007021
Gene Symbol: -
Cross references: -
693 Possible Orthologues:

Ensembl ID : ENSBBBG00000002083
Gene Symbol: -
Cross references: -
168 Possible Orthologues:

Ensembl ID : ENSBBBG00000015246
Gene Symbol: -
Cross references: -
297 Possible Orthologues:

Ensembl ID : ENSBBBG00000015238
Gene Symbol: -
Cross references: -
393 Possible Orthologues:

Ensembl ID : ENSBBBG00000012412
Gene Symbol: -
Cross references: -
403 Possible Orthologues:

Ensembl ID : ENSBBBG00000007434
Gene Symbol: -
Cross references: -
295 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).